Ahmed Hassan Fahal | Academic Influence

Ahmed Hassan Fahal's AcademicInfluence.com Rankings

Ahmed Hassan Fahal

Biology

#14566

World Rank

#18346

Historical Rank

Microbiology

#940

World Rank

#1037

Historical Rank

biology Degrees

Download Badge

Biology

Ahmed Hassan Fahal's Degrees

Masters Medicine University of Khartoum
Masters Medical Microbiology University of Khartoum
PhD Medical Mycology University of Khartoum

Why Is Ahmed Hassan Fahal Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ahmed Hassan Fahal is a Sudanese Professor of Surgery at the University of Khartoum, who specialised in Mycetoma. Life and career Early life and education Fahal was born on 25 December 1956 in Khartoum, Sudan. Fahal obtained a Bachelor of Medicine, Bachelor of Surgery with a Distinction from the University of Khartoum in 1979, a Master of Surgery in 1984, before becoming a Doctor of Medicine in 1996.

(See a Problem?)

Ahmed Hassan Fahal's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mycetoma: a thorn in the flesh. (2004) (251)
Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. (2004) (222)
Mycetoma: a unique neglected tropical disease. (2016) (198)
Neglected endemic mycoses. (2017) (169)
Mycetoma in the Sudan: An Update from the Mycetoma Research Centre, University of Khartoum, Sudan (2015) (121)
Mycetoma Medical Therapy (2014) (114)
Integrated Control and Management of Neglected Tropical Skin Diseases (2017) (104)
Management of mycetoma: major challenge in tropical mycoses with limited international recognition (2007) (102)
Environmental Occurrence of Madurella mycetomatis, the Major Agent of Human Eumycetoma in Sudan (2002) (99)
Revision of agents of black-grain eumycetoma in the order Pleosporales (2014) (92)
The Mycetoma Knowledge Gap: Identification of Research Priorities (2014) (83)
Eumycetoma and actinomycetoma – an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy (2015) (77)
Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. (2007) (75)
The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis. (2011) (75)
Merits and Pitfalls of Currently Used Diagnostic Tools in Mycetoma (2014) (74)
Ultrasonographic imaging of mycetoma (1997) (70)
Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis. (1999) (70)
In Vitro Susceptibilities of Madurella mycetomatis to Itraconazole and Amphotericin B Assessed by a Modified NCCLS Method and a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5- Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2H- Tetrazolium Hydroxide (XTT) Assay (2004) (70)
Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan. (2012) (64)
Streptomyces sudanensis sp. nov., a new pathogen isolated from patients with actinomycetoma (2008) (63)
The Surgical Treatment of Mycetoma (2016) (61)
A New Model for Management of Mycetoma in the Sudan (2014) (60)
The host tissue reaction to Madurella mycetomatis: new classification. (1995) (60)
Phylogenetic Findings Suggest Possible New Habitat and Routes of Infection of Human Eumyctoma (2013) (58)
Mycetoma in children in Sudan. (2010) (55)
Closing the mycetoma knowledge gap. (2018) (54)
Mycetoma laboratory diagnosis: Review article (2017) (54)
Mapping the Potential Risk of Mycetoma Infection in Sudan and South Sudan Using Ecological Niche Modeling (2014) (51)
Polymorphisms in Genes Involved in Innate Immunity Predispose Toward Mycetoma Susceptibility (2007) (50)
Development of a Species-Specific PCR-Restriction Fragment Length Polymorphism Analysis Procedure for Identification ofMadurella mycetomatis (1999) (50)
A holistic approach to the mycetoma management (2018) (49)
Fine needle aspiration cytology of mycetoma. (1996) (48)
New MRI grading system for the diagnosis and management of mycetoma. (2012) (45)
The management of mycetoma. (2010) (44)
Mycetoma: The Spectrum of Clinical Presentation (2018) (42)
Nasal Carriage of Staphylococcus aureusand Epidemiology of Surgical-Site Infections in a Sudanese University Hospital (1998) (41)
Femorofemoral bypass in unilateral iliac artery occlusion (1989) (41)
In Vitro Antifungal Activity of Isavuconazole against Madurella mycetomatis (2012) (41)
In vitro antifungal susceptibility of coelomycete agents of black grain eumycetoma to eight antifungals. (2015) (40)
A Madurella mycetomatis Grain Model in Galleria mellonella Larvae (2015) (40)
Mycetoma: A Long Journey from Neglect (2016) (39)
In Vitro Susceptibility of Madurella mycetomatis to Posaconazole and Terbinafine (2011) (39)
Medical education in the Sudan: its strengths and weaknesses (2007) (38)
Mycetoma caused by Madurella mycetomatis: a completely neglected medico-social dilemma. (2013) (38)
A murine model of Madurella mycetomatis eumycetoma. (2003) (37)
Application of Isothermal Amplification Techniques for Identification of Madurella mycetomatis, the Prevalent Agent of Human Mycetoma (2015) (36)
Madurella mycetomatis Is Highly Susceptible to Ravuconazole (2014) (36)
A Histopathological Exploration of the Madurella mycetomatis Grain (2013) (35)
The Diagnosis of Fungal Neglected Tropical Diseases (Fungal NTDs) and the Role of Investigation and Laboratory Tests: An Expert Consensus Report (2019) (34)
Rapid Identification of Black Grain Eumycetoma Causative Agents Using Rolling Circle Amplification (2014) (34)
Unexpected High Prevalence of Secondary Bacterial Infection in Patients with Mycetoma (1998) (34)
The Accuracy of Histopathological and Cytopathological Techniques in the Identification of the Mycetoma Causative Agents (2018) (33)
Head and Neck Mycetoma: The Mycetoma Research Centre Experience (2015) (33)
Mycetoma revisited. Incidence of various radiographic signs. (2009) (33)
Madurella mycetomatis Strains from Mycetoma Lesions in Sudanese Patients Are Clonal (2003) (33)
The orthopaedic aspects of mycetoma. (2014) (32)
Pleurostomophora ochracea, a Novel Agent of Human Eumycetoma with Yellow Grains (2012) (32)
Mycetoma: an old and still neglected tropical disease. (2015) (30)
In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin. (2007) (29)
Madurella mycetomatis Is Not Susceptible to the Echinocandin Class of Antifungal Agents (2010) (28)
Fournier's gangrene in Khartoum. (1988) (28)
IgG4 Subclass-Specific Responses to Staphylococcus aureus Antigens Shed New Light on Host-Pathogen Interaction (2014) (27)
Polymorphisms in catechol-O-methyltransferase and cytochrome p450 subfamily 19 genes predispose towards Madurella mycetomatis-induced mycetoma susceptibility. (2010) (26)
Predictors of Post-operative Mycetoma Recurrence Using Machine-Learning Algorithms: The Mycetoma Research Center Experience (2016) (26)
Pathological fractures in mycetoma. (1996) (25)
A new technique for the diagnosis of mycetoma using fixed blocks of aspirated material. (2010) (25)
Minor Role for BRCA2 (Exon11) and p53 (Exon 5–9) Among Sudanese Breast Cancer Patients (2004) (25)
The immunopathology of actinomycetoma lesions caused by Streptomyces somaliensis. (2001) (25)
Draft Genome Sequence of the Human Pathogen Streptomyces somaliensis, a Significant Cause of Actinomycetoma (2012) (24)
The disabling consequences of Mycetoma (2018) (24)
Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim (2020) (23)
Fructose-bisphosphate aldolase and pyruvate kinase, two novel immunogens in Madurella mycetomatis. (2012) (23)
A Polymorphism in the Chitotriosidase Gene Associated with Risk of Mycetoma Due to Madurella mycetomatis Mycetoma–A Retrospective Study (2015) (23)
Mycetoma (1992) (21)
Internal fistula formation: an unusual complication of mycetoma. (1996) (21)
Th-1, Th-2 Cytokines Profile among Madurella mycetomatis Eumycetoma Patients (2016) (21)
The In Vitro Antifungal Activity of Sudanese Medicinal Plants against Madurella mycetomatis, the Eumycetoma Major Causative Agent (2015) (21)
Amphotericin B and terbinafine but not the azoles prolong survival in Galleria mellonella larvae infected with Madurella mycetomatis (2018) (21)
Mycetoma: A global medical and socio-economic dilemma (2017) (21)
Genome Sequence of Madurella mycetomatis mm55, Isolated from a Human Mycetoma Case in Sudan (2016) (20)
Cystic mycetoma: an unusual clinical presentation of Madurella mycetomatis infection. (1998) (19)
Association of IL‐10 and CCL5 single nucleotide polymorphisms with tuberculosis in the Sudanese population (2013) (19)
Mycetoma in Uganda: A neglected tropical disease (2020) (18)
The association between the interleukin-10 cytokine and CC chemokine ligand 5 polymorphisms and mycetoma granuloma formation. (2013) (18)
Interleukin-17 and matrix metalloprotease-9 expression in the mycetoma granuloma (2019) (18)
Intestinal obstruction in Khartoum. (1996) (18)
Mycetoma: epidemiology, treatment challenges, and progress (2015) (17)
SUSCEPTIBILITY OF THREE CLINICAL ISOLATES OF ACTINOMODURA MADURAE TO α-PINENE, THE BIOACTIVE AGENT OF PINUS PINASTER TURPENTINE OIL (2008) (17)
An epidemiological study on the occurrence of Staphylococcus aureus in superficial abscesses of patients presenting for surgery in a teaching hospital in Khartoum, Sudan. (2000) (17)
Mycetoma Herbal Treatment: The Mycetoma Research Centre, Sudan Experience (2013) (17)
Abdominal wall mycetoma: an unusual presentation. (1994) (16)
Bridging the knowledge gap on mycoses in Africa: Setting up a Pan‐African Mycology Working Group (2019) (16)
Aspiration sclerotherapy for hydroceles in the tropics. (1995) (16)
The Role of Interleukin-1 cytokine family (IL-1β, IL-37) and interleukin-12 cytokine family (IL-12, IL-35) in eumycetoma infection pathogenesis (2018) (15)
The Combination of Amoxicillin-Clavulanic Acid and Ketoconazole in the Treatment of Madurella mycetomatis Eumycetoma and Staphylococcus aureus Co-infection (2014) (15)
EBV Associated Breast Cancer Whole Methylome Analysis Reveals Viral and Developmental Enriched Pathways (2018) (14)
The Epidemiology of Mycetoma (2012) (13)
Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis (2017) (13)
Hand Mycetoma: The Mycetoma Research Centre Experience and Literature Review (2016) (13)
Proteomic analysis of the processes leading to Madurella mycetomatis grain formation in Galleria mellonella larvae (2020) (13)
Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects (2020) (12)
A preliminary study on the ultrastructure of Actinomadura pelletieri and its host tissue reaction. (1994) (11)
Chaetomium atrobrunneum causing human eumycetoma: The first report (2019) (11)
Association of Eumycetoma and Schistosomiasis (2013) (11)
Modelling the spatial distribution of mycetoma in Sudan (2021) (11)
Blood supply and vasculature of mycetoma. (1997) (11)
Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma (2022) (11)
Broncho-pleuro-cutaneous fistula and pneumothorax: Rare challenging complications of chest wall eumycetoma (2017) (10)
Active Matrix Metalloprotease-9 Is Associated with the Collagen Capsule Surrounding the Madurella mycetomatis Grain in Mycetoma (2014) (10)
Amphotericin B but not itraconazole is able to prevent grain formation in experimental Madurella mycetomatis mycetoma in mice (2015) (10)
Histopathological Approach in Diagnosis of Mycetoma Causative Agents: A Mini Review (2017) (10)
Mycetoma in West Africa. (2021) (10)
Aggressive clinical presentation of Mycetoma due to Actinomadura Pelletierii (2013) (10)
Leishmanial cholecystitis and colitis in a patient with visceral leishmaniasis. (1995) (10)
Case Reports Aggressive perineal and pelvic eumycetoma: An unusual and challenging problem to treat (2013) (9)
The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach (2020) (9)
In Vitro Interaction of Currently Used Azoles with Terbinafine against Madurella mycetomatis (2014) (9)
Madurella real-time PCR, a novel approach for eumycetoma diagnosis (2020) (9)
Management of hand infection in Khartoum. (1992) (9)
Gastrointestinal tract cancer in association with hepatitis and HIV infection. (1995) (9)
Multiple Mycetoma Lung Secondaries from Knee Eumycetoma: An Unusual Complication (2016) (9)
Actinomycetoma laboratory-based diagnosis: a mini-review. (2021) (9)
Drug therapy for Mycetoma (2018) (9)
Salivary gland tumours in the Sudan (1993) (9)
The developed molecular biological identification tools for mycetoma causative agents: An update. (2021) (8)
Host genetic susceptibility to mycetoma (2020) (8)
Vulval mycetoma: a rare cause of bladder outlet obstruction. (1998) (8)
Mycetoma-induced palatal deficiency and pharyngeal plexus dysfunction. (1996) (8)
Use of immunoblotting in testing Madurella mycetomatis specific antigen. (2016) (8)
Recovery of radiologically functionless obstructed kidneys. (1984) (8)
Acute idiopathic scrotal oedema in association with diabetic septic foot. (1993) (8)
VNTR confirms the heterogeneity of Madurella mycetomatis and is a promising typing tool for this mycetoma causing agent. (2018) (7)
Cyclosporine-A therapy-induced multiple bilateral breast and accessory axillary breast fibroadenomas: a case report (2010) (7)
Acute gluteal abscesses: injectable chloroquine as a cause. (1989) (7)
Eumycetoma Medical Treatment: Past, Current Practice, Latest Advances and Perspectives (2021) (7)
Mycetoma - a long journey out of the shadows. (2020) (7)
In vitro activity of antiseptic solutions against Madurella mycetomatis: implications for eumycetoma management (2015) (7)
Mycetoma Pulmonary Secondaries from a Gluteal Eumycetoma: An Unusual Presentation (2016) (6)
Managing mycetoma: guidelines for best practice (2013) (6)
Peripheral Blood Mononuclear Cells of Mycetoma Patients React Differently to Madurella mycetomatis Antigens than Healthy Endemic Controls (2013) (6)
Pathological fracture in mycetoma. (1996) (6)
Mycetoma caused by Microascus gracilis: a novel agent of human eumycetoma in Sudan. (2021) (6)
Human actinomycetoma caused by Actinomadura mexicana in Sudan: the first report. (2020) (6)
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole (2022) (6)
Madurella mycetomatis-Induced Massive Shoulder Joint Destruction: A Management Challenge (2016) (6)
Acute gluteal abscess following intramuscular chloroquine injection: a clinical and experimental study. (1991) (5)
Pattern of postoperative pyrexia in Khartoum. (1996) (5)
Lack of association between ABO blood groups and Rh factor and the tendency to develop mycetoma. (1996) (5)
Ultrasound‐guided fine‐needle aspiration cytology significantly improved mycetoma diagnosis (2022) (5)
Possible new routes of infection of human eumycetoma (2013) (5)
Mycetoma: the journey from neglect to recognition as a neglected tropical disease. (2021) (5)
Mycetoma spatial geographical distribution in the Eastern Sennar locality, Sennar State, Sudan. (2021) (5)
Mycetoma imaging: the best practice. (2021) (5)
Oral cavity eumycetoma: a rare and unusual condition. (2013) (4)
Detection of multiple mycetoma pathogens using fungal metabarcoding analysis of soil DNA in an endemic area of Sudan (2022) (4)
A study of 87 mycetoma patients seen at three health facilities in Nouakchott, Mauritania. (2021) (4)
Cell phenotypes, immunoglobulins and complement in lesions of eumycetoma caused by Madurella mycetomatis (2006) (4)
Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella (2022) (4)
The Khartoum call for action Khartoum, Sudan - 2019. (2021) (4)
Dual infection with mycetoma and tuberculosis: report of two cases. (1995) (4)
Development of the Global Mycetoma Working Group (2020) (4)
The seizure of illicit assets: patterns of civil forfeiture in Canada and Ireland (2017) (4)
Mycetoma of the mastoid bone. (1998) (4)
CD4+ T-lymphocytopenia in HIV-negative tuberculosis patients in Sudan. (2012) (4)
A possible role for ticks in the transmission of Madurella mycetomatis in a mycetoma-endemic village in Sudan. (2021) (4)
CHAPTER 83 – Mycetoma (2011) (4)
The use of traditional medicines among mycetoma patients (2020) (4)
Pyomelanin Secretion in Madurella mycetomatis Interferes with Spectrophotometric Endpoint Reading Using the Sensititre YeastOne alamarBlue Assay but Not with Visual Endpoint Reading (2019) (3)
The Mycetoma Research Centre experience during the COVID-19 pandemic: obstacles and beyond (2021) (3)
The challenges of recruitment in clinical trials in developing countries: the Mycetoma Research Centre experience. (2021) (3)
The cell block technique: a new diagnostic tool for mycetoma (2009) (3)
A Short-Tandem-Repeat Assay (MmySTR) for Studying Genetic Variation in Madurella mycetomatis (2020) (3)
Draft Genome Sequences of Three Clinical Isolates of Madurella mycetomatis, the Major Cause of Black-Grain Mycetoma (2020) (3)
Tongue actinomycetoma due to Actinomadura madurae: a rare clinical presentation. (2012) (3)
Pneumatosis cystoid intestinalis: a case report. (1994) (3)
Cervical spinal cord compression: a rare and serious complication of Actinomadura pelletieri actinomycetoma (2015) (3)
Surgery in mycetoma-endemic villages: unique experience. (2021) (3)
Metagenomics of black grains: new highlights in the understanding of eumycetoma. (2021) (3)
Detection of (1→3)-β-d-Glucan in Eumycetoma Patients (2016) (3)
Clinical epidemiological characteristics of mycetoma in Eastern Sennar locality, Sennar State, Sudan (2021) (3)
Aggressive uncontrolled gluteal eumycetoma invading the pelvic cavity and the spinal cord (2016) (2)
Fine needle aspiration cytology utility in the identification of Mycetoma causative agents: The Mycetoma Research Center experience. (2018) (2)
The Touch Imprint Cytology: A simple method for the diagnosis of mycetoma causative agents (2017) (2)
Calculi within an anal fistula tract (1997) (2)
The association of HLA-DRB1 and HLA-DQB1 alleles and the occurrence of eumycetoma in Sudanese patients (2014) (2)
Multiple extensive Madurella mycetomatis eumycetoma lesions: a case report and review of the literature. (2021) (2)
Dual infection with mycetoma and tuberculosis (2015) (2)
Skin endometriosis in Sudan. (1987) (2)
Is Mycetoma a Vector-Borne Disease: The First Report on the Detection of Madurella mycetomatis in Ticks (2019) (2)
Post-prostatectomy auto-irrigation with furosemide in the tropics. (1986) (1)
Knowledge, attitudes and practices of surgical staff at Khartoum State hospitals towards Hepatitis B infection (2016) (1)
Immunoglobulin and inflammatory markers profiles in mycetoma. (1996) (1)
Madurella mycetomatis causing multiple mycetoma lesions: A rare clinical presentation (2019) (1)
Madurella mycetomatis grains within a eumycetoma lesion are clonal (2022) (1)
Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for In Vitro Susceptibility Testing of Itraconazole, Posaconazole, and Voriconazole against Madurella mycetomatis (2021) (1)
Thyroid function in patients with mycetoma. (1995) (1)
Abstracts of the 5th International Conference on Mycetoma (2012) (1)
Madurella mycetomatis compounds cross-reactive with galactomannan are detectable in culture supernatant but not in serum. (2007) (1)
Individual Risk Factors of Mycetoma Occurrence in Eastern Sennar Locality, Sennar State, Sudan: A Case-Control Study (2022) (1)
Infusion therapy: Knowledge among young doctors in two tertiary teaching hospitals in Khartoum (2013) (1)
Invasive, aggressive mastoid bone eumycetoma: a treatment challenge. (2021) (1)
Severely stigmatised skin neglected tropical diseases: a protocol for social science engagement (2020) (1)
Methylome analysis reveals dysregulated developmental and viral pathways in breast cancer (2015) (1)
Comparing the performance of the common used eumycetoma diagnostic tests (2022) (1)
The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma (2021) (1)
Systematic whole-genome sequencing reveals an unexpected diversity among actinomycetoma pathogens and provides insights into their antibacterial susceptibilities (2022) (0)
Massive complicated secondary inguinal mycetoma: a case series. (2021) (0)
Case Reports Fat necrosis of the breast in diabetic patients (2016) (0)
Estimating the burden of mycetoma in Sudan for the period 1991–2018 using a model-based geostatistical approach (2022) (0)
Structures produced by Madurella mycetomatis and Thielavia subthermophila . (2013) (0)
Inthisshortcommunication,wereportontwodiabeticpatientswhopresentedwithbreastlumpsthatproved tobebreastfatnecrosis.Thefirstwasa60-years-oldfemalediabeticpatientwhopresentedwithbilateral painfulbreastlumps.Thesecondwasa45-years-oldfemalenewlydiscovereddiabeticwhopresentedwith adeepulceratingrightbreas (2014) (0)
Long-standing gluteal mass: an uncommon presentation of tuberculosis ( Case Report ) (2014) (0)
Assessing information and communication technology in surgical training, Sudan as example (2012) (0)
Thetriadofpainlesssubcutaneousmass,multiplesinusesandsero-purulentdischargecontaininggrainsis pathognomicofmycetoma.Itmayspreadtoinvolvetheskinandthedeepstructuresresultingindestruction, deformityandlossoffunction.Mycetomacommonlyproducesvariousdisabilitiesanddeformities&inmany (2011) (0)
Metagenomics of Black Grains: New Highlights in the Understanding Eumycetoma (2020) (0)
Characterisation of the Madurella mycetomatis mycetoma granuloma tissue pigments and fibrous tissue (2016) (0)
S4.5b A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan—pharmacokinetic results (2022) (0)
Metagenomic detection of eumycetoma causative agents from households of patients residing in two Sudanese endemic villages in White Nile State (2022) (0)
S4.5d Comparing the diagnostic performance of the commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the gold standard (2022) (0)
Oral presentations (2008) (0)
Oral presentations (2008) (0)
Infusion Therapy: Knowledge among young doctors in two tertiary teaching hospitals in hospitals in Khartoum (2014) (0)
Oral presentations (2008) (0)
Ossification of the penis: report of two cases. (1996) (0)
Correction for Nyuykonge et al., “Pyomelanin Secretion in Madurella mycetomatis Interferes with Spectrophotometric Endpoint Reading Using the Sensititre YeastOne alamarBlue Assay but Not with Visual Endpoint Reading” (2020) (0)
Role of special stains in identification of fungi in eumycetoma among Sudanese patients in Soba University Hospital (2021) (0)
Diagnostics to support mycetoma management—Development of two target product profiles (2022) (0)
THE MYCE TOMA RESEA RCH CEN TR E, UNIVE RSI TY OF KHA RT OUM , SU DAN: A SU CCESS ST ORY THA T NEED S UPPO RT (2013) (0)
The photomicrography shows melanin in the grain. (2013) (0)
S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan—top line results (2022) (0)
Clinical Images: Aggressive actinomycetoma (2016) (0)
UvA-DARE ( Digital Academic Repository ) Revision of agents of black-grain eumycetoma in the order (2014) (0)
Visual ethnographic documentation: a novel tool for mycetoma awareness and advocacy (2022) (0)
Report on the Mycetoma Medical & Health Third Mission to Wad Onsa and Wad El Nimir villages, Sinner State 31st March - 1st April 2016 (2016) (0)
Genomics and metagenomics of Madurella mycetomatis, a causative agent of black grain mycetoma in Sudan (2022) (0)
Using a Madurella mycetomatis‐specific PCR on grains obtained via non‐invasive fine‐needle aspirated material is more accurate than cytology (2023) (0)
Staphylococcus aureus causing primary foot Botryomycosis mimicking actinomycetoma: a case report from Sudan. (2022) (0)
Why the mycetoma patients are still neglected (2022) (0)
Susceptibility Immunity Predispose Toward Mycetoma Polymorphisms in Genes Involved in Innate and Alex van Belkum (2007) (0)
Hospitalin a Sudanese University aureusand Epidemiology of Surgical-Site Nasal Carriage of Staphylococcus (2013) (0)
Eumycetoma with pulmonary dissemination an unusual complication: Case series and literature review (2022) (0)
Identification of M. mycetomatis fungus in pleural fluid and sputum of a patient with aggressive gluteal eumycetoma with pulmonary spread (2016) (0)
S4.5c Using serum beta-glucan measurements and sequencing of the Madurella mycetomatis azole target gene to predict therapeutic outcome during azole treatment in human mycetoma (2022) (0)
Olorofim is potent against Madurella mycetomatis – the most common causative agent of Eumycetoma (2020) (0)
Role of socioeconomic factors in developing mycetoma: Results from a household survey in Sennar State, Sudan (2022) (0)
Mycetoma management and clinical outcomes: the Mycetoma Research Center experience. (2022) (0)
Oral Presentations (2000) (0)
Oral Presentations (2000) (0)
Orignal Article: Fine needle aspiration for cytology: A diagnostic tool for breast lesions in low resources areas. (2016) (0)
WHO EMRO | Global conference calls for action to prevent suffering and disability from mycetoma (2019) (0)
Oral Presentations (2010) (0)
Epidemiological cut‐off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma (2022) (0)
P445 Clinical evaluation of the performance of the most commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the golden standard (2022) (0)
University of Groningen IgG 4 subclass-specific responses to Staphylococcus aureus antigens shed new light on host-pathogen interaction (2017) (0)
Extensive perineal Actinomadura pelletieri actinomycetoma-induced urethral stricture: a rare complication. (2021) (0)
S3.1a Update in mycetoma control (2022) (0)
Thisisareportona35-years-oldmaleteacherfromCentralSudanwhopresentedwithanaggressive uncontrolledrightglutealeumycetomacausedbyM.Mycetomatisof16yearsduration.Iteventually invadedthepelviccavityandlowerspinalcordinspiteofthelongtermmedicaltreatmentandrepeated aggressiveexcisionsthatculminatedinrighthi (2014) (0)
Iron regulatory pathways differentially expressed during Madurella mycetomatis grain development in Galleria mellonella (2022) (0)
Technology in Surgical Education (2016) (0)
Wako β‐D‐glucan assay can be used to measure serum β‐D‐glucan in Sudanese patients to aid with diagnosis of eumycetoma caused by Madurella mycetomatis (2022) (0)
S6.5b Genomics and metagenomics of Madurella mycetomatis (2022) (0)
Eye Eumycetoma: The Mycetoma Research Centre Case Series (2014) (0)
Incidence of various radiographic signs (2009) (0)
Vertebral solitary osteochondroma: report of three cases (1988) (0)
Original Article The pathogenesis of unilateral venous varicosity observed in patients with mycetoma (2011) (0)

This paper list is powered by the following services:

Other Resources About Ahmed Hassan Fahal

en.wikipedia.org

What Schools Are Affiliated With Ahmed Hassan Fahal?

Ahmed Hassan Fahal is affiliated with the following schools:

University of Khartoum